Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Active Implants Appoints And To Board July 11, 2017 <b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017 Argentum And Eli Lilly Settle Patent Dispute Over CIALIS August 22, 2017
<b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017